Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Archive

FIVE at FIVE: Steve Rowe’s M&S tenure, ANGLE achieves FDA clearance, Musk's wealth plummets and cheap Pets at Home…

Here’s Proactive’s round-up of the top financial stories of the day, with helpful links taking you directly to the news

1. Has M&S's Steve Rowe been a success?

On share price movement alone, it would seem he’s the only one to believe that with the shares down 69% since April 2016, the point at which he took the helm.

Read more

2. ANGLE scores liquid biopsy sign off from FDA

The company reckons the De Novo approval from the American regulator heralds a new era for personalised cancer care.

Read more

3. Musk’s net worth drops below US$200bn

Tesla’s share price fell 7% overnight knocking Musk’s net worth to a mere US$192.7bn.

Read more

4. FTSE 100 gains as FOMC minutes eyed

At the close, the UK blue-chip index was 38.40 points, or 0.5% higher at 7,522.75, below the session peak of 7,546.41 but above the day's low of 7,484.35.

Read more

5. Pets at Home may be cheap, says broker

For the year to the end of March, the retailer and pet services provider reported an underlying profit before tax of £144.7mln for the 53-week period to 31 March, representing 61.1% growth on the prior year

Read more

Let’s take a look ahead at some of tomorrow’s news

Wickes United Utilities top tomorrow's update

Read more

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK